The UK’s Advanced Research and Innovation Agency (ARIA) was established in 2023 with the goal of pursuing “high-risk, high-reward” moonshots in sectors ranging from bolstering food security to new ways of ramping up
In 2010, a university lecturer from Colorado started experiencing worrying signs of cognitive decline. The lecturer—a 63-year-old viral immunologist whose identity has been kept anonymous—suffered alarming symptoms, including impaired memory, waning concentration, and
Living in South Australia, the hottest and driest of Australia’s six states, and feeling the brunt of the region’s increasingly intense seasonal heat waves, local researchers wanted to know more about the impact
On average, the typical American contracts two to three colds per year between September and May, at an estimated cost of around $40 billion to the economy. Effective forms of treating or preventing
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea. The gene-editing technology Crispr is best known for delivering
For decades, the discussion around autism has been a hotbed of misinformation, misinterpretation, and bad science, ranging from the long-discredited link between the neurodevelopmental condition and vaccines, to newer claims that going gluten-free
For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford pediatrician
The moment Merry Fitzpatrick realized that Gaza’s malnutrition crisis had progressed to a newer and deadlier phase was when surgeons at the few hospitals still operational on the Strip reported that wounds were
In 2023, Mitchell Miller, a sleep medicine doctor based in Clearwater, Florida, received a visit from an unusual patient. While Miller is accustomed to seeing people with sleep apnea—a persistent condition in which
Across the African continent, the focus on disease has long been on infectious killers such as HIV and tuberculosis. But in early February, around 700 policymakers, academics, and philanthropists convened in Kigali, Rwanda,
